Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd. - PE Ratioverified

DNPUF

Price:

$9.41

Market Cap:

$659.21B

Sumitomo Pharma Co., Ltd. is a global enterprise specializing in the manufacturing and distribution of a diverse portfolio of products, including pharmaceuticals, food ingredients and additives, chemical product materials, and veterinary medicines. Its operations span key international markets, notably Japan, North America, and China. The company's extensive pharmaceutical division develops and markets therapeutic agents for a wide array of medical conditions. These encompass neurological disorders such as Parkinson's disease and epilepsy; mental health challenges including depression and atypical psychosis; cardiovascular issues like hypertension, angina pectoris, and arrhythmia; and metabo...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2012-01-17

Stock Exchange

OTC

Ticker

DNPUF

The PE Ratio as of June 2026 (TTM) for Sumitomo Pharma Co., Ltd. (DNPUF) is 5.60

According to Sumitomo Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 5.60. This represents a change of -110.29% compared to the average of -54.42 of the last 4 quarters.

Sumitomo Pharma Co., Ltd. (DNPUF) Historical PE Ratio (quarterly & annually)

How has DNPUF PE Ratio performed in the past?

The mean historical PE Ratio of Sumitomo Pharma Co., Ltd. over the last ten years is 11.00. The current 5.60 PE Ratio has changed 4.99% with respect to the historical average. Over the past ten years (40 quarters), DNPUF's PE Ratio was at its highest in in the September 2016 quarter at 75.70. The PE Ratio was at its lowest in in the March 2017 quarter at -314.73.

Quarterly (TTM)
Annual

Average

11.00

Median

12.77

Minimum

-4.32

Maximum

23.32

Sumitomo Pharma Co., Ltd. (DNPUF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sumitomo Pharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 69.13%

Maximum Annual PE Ratio = 23.32

Minimum Annual Increase = -2492.85%

Minimum Annual PE Ratio = -4.32

Quarterly (TTM)
Annual
YearPE RatioChange
20267.72-37.03%
202512.25-2492.85%
2024-0.51-88.14%
2023-4.32-150.76%
20228.51-37.53%
202113.62-0.43%
202013.68-39.09%
201922.4569.13%
201813.28-43.07%
201723.3211.84%

Sumitomo Pharma Co., Ltd. (DNPUF) Average PE Ratio

How has DNPUF PE Ratio performed in the past?

The current PE Ratio of Sumitomo Pharma Co., Ltd. (DNPUF) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

6.49

5-year avg

4.73

10-year avg

11.00

Sumitomo Pharma Co., Ltd. (DNPUF) PE Ratio vs. Peers

How is DNPUF’s PE Ratio compared to its peers?

Sumitomo Pharma Co., Ltd.’s PE Ratio is less than Livzon Pharmaceutical Group Inc. (13.20), less than Siegfried Holding AG (17.65), less than Santen Pharmaceutical Co., Ltd. (16.43), less than The United Laboratories International Holdings Limited (6.27), less than H. Lundbeck A/S (11.15), greater than Hikma Pharmaceuticals PLC (0.18), less than Welcia Holdings Co., Ltd. (40.81), less than Carl Zeiss Meditec AG (12.86), less than Carl Zeiss Meditec AG (12.86), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (33.76),

Build a custom stock screener for Sumitomo Pharma Co., Ltd. (DNPUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sumitomo Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sumitomo Pharma Co., Ltd. (DNPUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sumitomo Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sumitomo Pharma Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Sumitomo Pharma Co., Ltd. (DNPUF)?

What is the highest PE Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?

What is the 3-year average PE Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?

What is the 5-year average PE Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?

How does the current PE Ratio for Sumitomo Pharma Co., Ltd. (DNPUF) compare to its historical average?